Latest News and Press Releases

Emerging drugs market is expected to rise from $383.9 billion in 2024 to $558.0 billion by 2030, driven by faster regulations and increased R&D spending.

AGC Biologics expands its partnership with Novelty Nobility to manufacture a bispecific antibody in Japan.

White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical...

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2025 Edition)" report has been added to ResearchAndMarkets.com's offering. The growth of this Market is expected to be...

AGC Biologics is the 2026 Fierce Outsourcing Award recipient for Leadership in Regulatory and Quality Compliance.

St. Louis, MO, April 23, 2026 (GLOBE NEWSWIRE) -- Leinco Technologies, a leader in antibody and protein development, and CellCarta, a global provider of precision medicine laboratory services, are...

Bolstered leadership team positions Paratus to accelerate PS-1001 toward the clinic and build a pipeline of differentiated medicines.

 Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for Phase 3 development in DPNP New data on spasticity further...

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Measuring Performance in Clinical Research Management (May 6, 2026)" training has been added to ResearchAndMarkets.com's offering. This...

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Drug Development Services Market Report 2026" has been added to ResearchAndMarkets.com's offering. The drug development services market has...